Company
Phagenesis
At Phagenesis, we’re transforming the future of neurogenic dysphagia treatment
Also known as Phagenesis, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Customers
- healthcare provider
- Legal name
- Phagenesis, Inc.
- phagenesis.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 17 September 2026
About
Built on pioneering research into the brain-to-swallow connection, Phagenesis is a leader in delivering targeted pharyngeal electrical stimulation to restore neural pathways for safe, efficient swallowing
Funding snapshot
- Total raised
- $42MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series D+, $42M2024-03-04
Funding rounds
- Series D+
- $42M2024-03-04, Company stated
Products
- Hardware
- Phagenyx
Loading relationship preview